230 related articles for article (PubMed ID: 23729692)
1. Secondary prevention by stroke subtype: a nationwide follow-up study in 46 108 patients after acute ischaemic stroke.
Kim D; Lee SH; Joon Kim B; Jung KH; Yu KH; Lee BC; Roh JK;
Eur Heart J; 2013 Sep; 34(35):2760-7. PubMed ID: 23729692
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet therapy as a modulator of stroke aetiology: a meta-analysis.
Rajkumar CA; Floyd CN; Ferro A
Br J Clin Pharmacol; 2015 Sep; 80(3):331-41. PubMed ID: 25784356
[TBL] [Abstract][Full Text] [Related]
3. Stroke subtypes and interventional studies for transient ischemic attack.
Lavallée P; Amarenco P
Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
[TBL] [Abstract][Full Text] [Related]
4. Transient atrial fibrillation and risk of stroke after acute myocardial infarction.
Bishara R; Telman G; Bahouth F; Lessick J; Aronson D
Thromb Haemost; 2011 Nov; 106(5):877-84. PubMed ID: 21866303
[TBL] [Abstract][Full Text] [Related]
5. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
Davis SM; Donnan GA
N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
[No Abstract] [Full Text] [Related]
6. Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA.
Sandercock P; Lindley R; Wardlaw J
Br J Hosp Med; 1992 May 20-Jun 2; 47(10):731-7. PubMed ID: 1606457
[TBL] [Abstract][Full Text] [Related]
7. Secondary prevention in the acute and early chronic phase after ischaemic stroke and transient ischaemic attacks with antiplatelet drugs--is antiplatelet monotherapy still reasonable?
Diener HC; Weber R; Weimar C; Röther J
Int J Clin Pract; 2011 May; 65(5):531-5. PubMed ID: 21489077
[No Abstract] [Full Text] [Related]
8. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
[TBL] [Abstract][Full Text] [Related]
9. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
Weber R; Weimar C; Diener HC
Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
Aw D; Sharma JC
Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
[TBL] [Abstract][Full Text] [Related]
11. Filling the gap between science & clinical practice: prevention of stroke recurrence.
Russolillo A; Di Minno MN; Tufano A; Prisco D; Di Minno G
Thromb Res; 2012 Jan; 129(1):3-8. PubMed ID: 21907395
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: a consecutive cross-sectional survey.
Wang YL; Wu D; Nguyen-Huynh MN; Zhou Y; Wang CX; Zhao XQ; Liao XL; Liu LP; Wang YJ;
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):775-81. PubMed ID: 20456429
[TBL] [Abstract][Full Text] [Related]
13. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
15. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
16. [Antiplatelet therapy: update in secondary stroke prevention].
Uchiyama S
Brain Nerve; 2013 Jul; 65(7):771-82. PubMed ID: 23832980
[TBL] [Abstract][Full Text] [Related]
17. Changes in antiplatelet use prior to incident ischaemic stroke over 7 years in a UK centre and the association with stroke subtype.
White JR; Bettencourt-Silva JH; Potter JF; Loke YK; Myint PK
Age Ageing; 2013 Sep; 42(5):594-8. PubMed ID: 23832263
[TBL] [Abstract][Full Text] [Related]
18. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial.
Doehner W; Schenkel J; Anker SD; Springer J; Audebert HJ
Eur Heart J; 2013 Jan; 34(4):268-77. PubMed ID: 23076781
[TBL] [Abstract][Full Text] [Related]
19. [Antithrombotic therapy in the secondary prevention of stroke].
Mel'nikova EV; Kadinskaia MI; Gerasimenko DV; Shmonin AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):23-7. PubMed ID: 21626814
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]